Navigation Links
Growing Shortage of Gastroenterologists to Affect Screening Capacity for #2 Cancer Killer
Date:1/7/2009

"GI Gap" To Worsen as the U.S. Population Ages; Projected Demand for Gastroenterologists is Growing at Nearly Double the Rate of Supply

Olympus Seeks Legislative Solution and Increased Awareness to Proactively Increase Number of Gastroenterology Fellowships

WASHINGTON, Jan. 7 /PRNewswire-USNewswire/ -- The United States is facing a shortage of gastroenterologists (GIs) that will total at least 1,050 of these specialty physicians by 2020, according to a first of its kind study from Olympus and The Lewin Group, a national healthcare and human services consulting firm. The new research illustrates that the aging population and increased colorectal cancer (CRC) screening rates will overwhelm the supply of GI physicians, challenging the nation's ability to provide adequate screening and treatment for the nation's number two cancer killer.

The Lewin research was commissioned by Olympus, the global leader in endoscopy, as part of a campaign to raise awareness about colorectal cancer screening and ensure screening is available to all who seek it. The new data was unveiled today and is available at www.olympusamerica.com/crcadvocacy.

"This GI shortage is a major concern for the U.S. healthcare system and Olympus is dedicated to finding solutions that increase the number of gastroenterologists and make CRC screening widely accessible," said F. Mark Gumz, president and CEO of Olympus Corporation of the Americas. "With approximately 149,000 new cases of colorectal cancer projected to be diagnosed in 2008, and an estimated 50,000 Americans projected to die from this treatable and beatable disease each year, it is critical to ensure that the U.S. has a sufficient workforce of trained gastroenterologists." In 2008, the supply of GI physicians active in patient care was estimated to be 10,390.

Gumz continued, "While the
'/>"/>

SOURCE Olympus
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Dr. Mitchell L. Petusevsky, M.D., F.C.C.P. Meets Growing Demand for the Treatment of Sleep and Pulmonary Disorders
2. Veteran Rehab Specialist, Ted ONeill, Joins Fast-Growing Alliance Seating & Mobility in Pennsylvania
3. Launch of New Independent Aging Company Will Address the Needs of the Growing Senior Population
4. Colorectal Cancer Racial Gap Still Growing
5. Leading U.S. Cancer Organizations Unite Against the Growing Global Cancer Burden
6. NHHF Scholarship Program Targets Growing Demand for Diversity Among Health Care Professionals
7. CPF Updates Patient Education Materials to Meet Growing Demand for Pulmonary Fibrosis Information
8. Americas 5000 Fastest-Growing Private Companies Revealed
9. Happiness Spreads Through African Villages Thanks to Growing Contributions from Long Term Care Insurance Professionals
10. NxStage(R) Ranked 14th Fastest Growing Company in North America on Deloittes 2008 Technology Fast 500
11. Sonic Innovations Launches New Product to Meet Growing Consumer Need and Demand for Digital Hearing Aids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
(Date:12/4/2009)Rockville, MD "Why is it that men can be bastards and women must wear pearls and smile?" wrote author Lynn Hecht Schafran. The answer, according to an article in the Journal of Vision , may lie in
Breaking Medicine News(10 mins):Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Are angry women more like men? 2
... May 20 moksha8, Inc. announced today that it has...commercialize an additional portfolio of products ...on USD. , , moksha8 will commercialize products ..., Rocephin(R) and Bactrim(R). , , "moksha8 has ...
... Malchow Join Digirad Board of Directors , , POWA...DRAD ) today announced that it has named veteran h.... Malchow to its Board of Directors, effective imm...d business acumen that will make them immediate co...
...y Keeps the Doctor Away - Using QlikView, Inside I...ealth market trends such as tracking the progressi...tive profiling of disease trends. Essentially, Qli...9 -- The Australian health and pharmaceutical indu...
...growing personal injury law firms in Connecticut s...case management team that stays in frequent contac...n, Conn. (Lexis Nexis) May 20, 2009 -- Jonathan P... addition of two seasoned litigators to its team.,...
...Spinal Muscular Atrophy has just launched a new Me... MAC is one of the most highly respected bodies of...ting the agenda for proactive, creative, and colla...es, health care providers, and the public about SM...
...oint Call for Presidential Action on Cancer Policy...or and foundation director, will present a six-poi...ach to cancer prevention, screening, treatment and...ress Building, 529 14th St., N.W. , , (Logo: ht...
Other Medicine News:Health News:moksha8 Expands Alliance With Roche to Commercialize $200 Million of Products in Brazil and Mexico 2Health News:Digirad Names Two Veteran Healthcare Executives to Board 2Health News:Digirad Names Two Veteran Healthcare Executives to Board 3Health News:Digirad Names Two Veteran Healthcare Executives to Board 4Health News:Innovative Business Intelligence Software Helps Keep Australia Healthy this Winter 2Health News:Innovative Business Intelligence Software Helps Keep Australia Healthy this Winter 3Health News:Jonathan Perkins Injury Lawyers Adds Two Experienced Litigation Attorneys to Connecticut Team 2Health News:Families of Spinal Muscular Atrophy Announces its New Medical Advisory Council 2Health News:Families of Spinal Muscular Atrophy Announces its New Medical Advisory Council 3
(Date:12/3/2009)ALISO VIEJO, Calif. and STATE COLLEGE, Pa., Dec. 3 Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics,
(Date:12/3/2009)SAN DIEGO, Dec. 3 BioMed Realty Trust, Inc. (NYSE: BMR ) announced today that it has entered into a new lease with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) for approximately 131,000 square
(Date:12/3/2009)FORT WORTH, Texas, Dec. 3 Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM), a rapidly growing provider of specialty medical products, announced today an agreement with the Health In
Breaking Medicine Technology:Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3Prime Retail Launches Operation Shop Pink 56749 1Prime Retail Launches Operation Shop Pink 56749 2Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 1Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 2Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 3Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 4Mpex Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results with Aeroquin 28R 29 28MP 376 29 Treatment in Cystic Fibrosis Patients 13973 1Mpex Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results with Aeroquin 28R 29 28MP 376 29 Treatment in Cystic Fibrosis Patients 13973 2Mpex Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results with Aeroquin 28R 29 28MP 376 29 Treatment in Cystic Fibrosis Patients 13973 3Mpex Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results with Aeroquin 28R 29 28MP 376 29 Treatment in Cystic Fibrosis Patients 13973 4
...ll to be held on Wednesday, August 6, 2008 at 8:00...., Aug. 5 Isolagen(TM), Inc. (Amex:,ILE) announce...lts from two,pivotal, Phase III clinical studies (...rapy(TM) for the treatment of nasolabial folds, or...ial Protocol Assessment (SPA), met,all primary end...
... Nexgen Spine, a leading,developer of innovative ...nerative disc disease, announced today that it has...R) Lumbar Artificial Disc in the European,Union., ... Disc Prosthesis has,received CE mark approval," s...exgen Spine. "This represents an important milesto...
Other Medicine Technology:Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant 2Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant 3Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant 4Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant 5Nexgen Spine Receives CE Mark Approval for the Physio-L(R) Artificial Disc 2
...ty, comprehensive portable and bedside monitoring....o see up to four waveforms, including two vectors ...rough menus and is not impaired by gloves or tempe...els of ECG, heart/pulse rate, Smartcuf noninvasive...
...n allows emergency caregivers to establish an Emer...eded. Central Station monitoring can be deployed i...ions to increase the level and timeliness of care ...Welch Allyn's Propaq and Micropaq monitors, Mobile...
3775 Handheld Pulse Oximeter
... ,S/5 Clinical Communications is the newest gener... you and your care team to provide effective, high...ential patient information and be able to share it...of time and location. Clinical communication produ...
Medicine Products: